Eli Lilly and Company (LLY)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 02:07PM EDT. Market open.
| Previous close | 771.55 |
| Open | 774.02 |
| Bid | 764.01 x 1100 |
| Ask | 764.28 x 900 |
| Day's range | 762.39 - 777.42 |
| 52-week range | 419.80 - 800.78 |
| Volume | |
| Avg. volume | 2,898,758 |
| Market cap | 725.625B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 112.44 |
| EPS (TTM) | 6.79 |
| Earnings date | 08 Aug 2024 |
| Forward dividend & yield | 5.20 (0.67%) |
| Ex-dividend date | 15 May 2024 |
| 1y target est | 856.61 |
ZacksPharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
Investor's Business DailyHow A Top Fund Beats The Market By Owning Future Leaders
Julianne McHugh, lead manager of best mutual fund BNY Mellon Large Cap Securities, isn't interested in blue-chip stars of yesteryear.
ZacksZacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
Eaton, Eli Lilly and Arista Networks have been highlighted in this Investment Ideas article.
© 2024 Yahoo. All rights reserved.